Hunan Fangsheng Pharm Co Ltd (SHG:603998) — Market Cap & Net Worth

$675.92 Million USD · CN¥4.62 Billion CNY · Rank #10908

Market Cap & Net Worth: Hunan Fangsheng Pharm Co Ltd (603998)

Hunan Fangsheng Pharm Co Ltd (SHG:603998) has a market capitalization of $675.92 Million (CN¥4.62 Billion) as of September 24, 2026. Listed on the SHG stock exchange, this China-based company holds position #10908 globally and #3039 in its home market, demonstrating a 1.06% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hunan Fangsheng Pharm Co Ltd's stock price CN¥10.52 by its total outstanding shares 439081360 (439.08 Million). Also see Hunan Fangsheng Pharm Co Ltd assets under control for a full breakdown of the balance sheet.

Hunan Fangsheng Pharm Co Ltd Market Cap History: 2015 to 2026

Hunan Fangsheng Pharm Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $982.26 Million to $675.92 Million (-0.19% CAGR). Also see cash flow conversion of Hunan Fangsheng Pharm Co Ltd for how efficiently the company converts equity into cash flow.

Hunan Fangsheng Pharm Co Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Hunan Fangsheng Pharm Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Hunan Fangsheng Pharm Co Ltd (603998) share price today for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

0.41x

Hunan Fangsheng Pharm Co Ltd's market cap is 0.41 times its annual revenue

Industry average: 0.64x Lower than industry average

Latest Price to Earnings (P/E) Ratio

2.36x

Hunan Fangsheng Pharm Co Ltd's market cap is 2.36 times its annual earnings

Industry average: 5.48x Lower than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$1.03 Billion	$534.26 Million	$69.76 Million	1.93x	14.77x
2017	$654.77 Million	$720.77 Million	$59.68 Million	0.91x	10.97x
2018	$273.60 Million	$1.05 Billion	$72.99 Million	0.26x	3.75x
2019	$488.46 Million	$1.09 Billion	$78.91 Million	0.45x	6.19x
2020	$359.11 Million	$1.28 Billion	$63.79 Million	0.28x	5.63x
2021	$411.54 Million	$1.57 Billion	$70.04 Million	0.26x	5.88x
2022	$504.53 Million	$1.79 Billion	$285.85 Million	0.28x	1.77x
2023	$704.20 Million	$1.63 Billion	$186.82 Million	0.43x	3.77x
2024	$669.50 Million	$1.78 Billion	$255.22 Million	0.38x	2.62x
2025	$722.19 Million	$1.75 Billion	$306.39 Million	0.41x	2.36x

Competitor Companies of 603998 by Market Capitalization

Companies near Hunan Fangsheng Pharm Co Ltd in the global market cap rankings as of September 24, 2026. Review Hunan Fangsheng Pharm Co Ltd (603998) tangible equity ratio to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Hunan Fangsheng Pharm Co Ltd by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #524 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #586 globally with a market cap of $46.44 Billion USD.
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #638 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #651 globally with a market cap of $42.68 Billion USD ( CN¥291.65 Billion CNY).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#524	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#586	GALDERMA GROUP AG	NYSE:GALDY	$46.44 Billion	$39.83
#638	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€16.50
#651	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$42.68 Billion	CN¥45.72

Hunan Fangsheng Pharm Co Ltd Historical Marketcap From 2015 to 2026

Between 2015 and today, Hunan Fangsheng Pharm Co Ltd's market cap moved from $982.26 Million to $ 675.92 Million, with a yearly change of -0.19%.

Year	Market Cap	Change (%)
2026	CN¥675.92 Million	-6.41%
2025	CN¥722.19 Million	+7.87%
2024	CN¥669.50 Million	-4.93%
2023	CN¥704.20 Million	+39.57%
2022	CN¥504.53 Million	+22.60%
2021	CN¥411.54 Million	+14.60%
2020	CN¥359.11 Million	-26.48%
2019	CN¥488.46 Million	+78.53%
2018	CN¥273.60 Million	-58.22%
2017	CN¥654.77 Million	-36.44%
2016	CN¥1.03 Billion	+4.88%
2015	CN¥982.26 Million	--

End of Day Market Cap According to Different Sources

On Sep 23rd, 2026 the market cap of Hunan Fangsheng Pharm Co Ltd was reported to be:

Source	Market Cap
Yahoo Finance	$675.92 Million USD
MoneyControl	$675.92 Million USD
MarketWatch	$675.92 Million USD
marketcap.company	$675.92 Million USD
Reuters	$675.92 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Hunan Fangsheng Pharm Co Ltd

SHG:603998 China Drug Manufacturers - Specialty & Generic

Market Cap

$675.92 Million

CN¥4.62 Billion CNY

Market Cap Rank

#10908 Global

#3039 in China

Share Price

CN¥10.52

Change (1 day)

-1.77%

52-Week Range

CN¥8.85 - CN¥13.01

All Time High

CN¥18.09